107 related articles for article (PubMed ID: 18349419)
1. Characterization of 5(6)-carboxy-2,'7'-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4.
Heredi-Szabo K; Kis E; Molnar E; Gyorfi A; Krajcsi P
J Biomol Screen; 2008 Apr; 13(4):295-301. PubMed ID: 18349419
[TBL] [Abstract][Full Text] [Related]
2. Characterization of rhodamine-123, calcein and 5(6)-carboxy-2',7'-dichlorofluorescein (CDCF) export via MRP2 (ABCC2) in MES-SA and A549 cells.
Munić V; Hlevnjak M; Eraković Haber V
Eur J Pharm Sci; 2011 Aug; 43(5):359-69. PubMed ID: 21605668
[TBL] [Abstract][Full Text] [Related]
3. Impact of probe compound in MRP2 vesicular transport assays.
Kidron H; Wissel G; Manevski N; Häkli M; Ketola RA; Finel M; Yliperttula M; Xhaard H; Urtti A
Eur J Pharm Sci; 2012 May; 46(1-2):100-5. PubMed ID: 22406294
[TBL] [Abstract][Full Text] [Related]
4. A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein.
Siissalo S; Hannukainen J; Kolehmainen J; Hirvonen J; Kaukonen AM
Eur J Pharm Biopharm; 2009 Feb; 71(2):332-8. PubMed ID: 18775779
[TBL] [Abstract][Full Text] [Related]
5. Development of a fluorescence-based assay for drug interactions with human Multidrug Resistance Related Protein (MRP2; ABCC2) in MDCKII-MRP2 membrane vesicles.
Lechner C; Reichel V; Moenning U; Reichel A; Fricker G
Eur J Pharm Biopharm; 2010 Jun; 75(2):284-90. PubMed ID: 20307659
[TBL] [Abstract][Full Text] [Related]
6. Kinetic validation of the use of carboxydichlorofluorescein as a drug surrogate for MRP5-mediated transport.
Pratt S; Chen V; Perry WI; Starling JJ; Dantzig AH
Eur J Pharm Sci; 2006 Apr; 27(5):524-32. PubMed ID: 16337112
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Albumin on MRP2 and BCRP in the Vesicular Transport Assay.
Deng F; Sjöstedt N; Kidron H
PLoS One; 2016; 11(10):e0163886. PubMed ID: 27706255
[TBL] [Abstract][Full Text] [Related]
8. Transport of leukotriene C4 and structurally related conjugates.
Jedlitschky G; Keppler D
Vitam Horm; 2002; 64():153-84. PubMed ID: 11898391
[TBL] [Abstract][Full Text] [Related]
9. Identification of domains participating in the substrate specificity and subcellular localization of the multidrug resistance proteins MRP1 and MRP2.
Konno T; Ebihara T; Hisaeda K; Uchiumi T; Nakamura T; Shirakusa T; Kuwano M; Wada M
J Biol Chem; 2003 Jun; 278(25):22908-17. PubMed ID: 12682044
[TBL] [Abstract][Full Text] [Related]
10. Mutation of Trp1254 in the multispecific organic anion transporter, multidrug resistance protein 2 (MRP2) (ABCC2), alters substrate specificity and results in loss of methotrexate transport activity.
Ito K; Oleschuk CJ; Westlake C; Vasa MZ; Deeley RG; Cole SP
J Biol Chem; 2001 Oct; 276(41):38108-14. PubMed ID: 11500505
[TBL] [Abstract][Full Text] [Related]
11. Exploring the structure-activity relationships of ABCC2 modulators using a screening approach.
Wissel G; Kudryavtsev P; Ghemtio L; Tammela P; Wipf P; Yliperttula M; Finel M; Urtti A; Kidron H; Xhaard H
Bioorg Med Chem; 2015 Jul; 23(13):3513-25. PubMed ID: 25935289
[TBL] [Abstract][Full Text] [Related]
12. Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay.
Gilibili RR; Chatterjee S; Bagul P; Mosure KW; Murali BV; Mariappan TT; Mandlekar S; Lai Y
Drug Metab Dispos; 2017 Jun; 45(6):604-611. PubMed ID: 28325716
[TBL] [Abstract][Full Text] [Related]
13. The vesicular transport assay: validated in vitro methods to study drug-mediated inhibition of canalicular efflux transporters ABCB11/BSEP and ABCC2/MRP2.
Herédi-Szabó K; Kis E; Krajcsi P
Curr Protoc Toxicol; 2012 Nov; Chapter 23():Unit 23.4. PubMed ID: 23169269
[TBL] [Abstract][Full Text] [Related]
14. Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2).
Zimmermann C; van de Wetering K; van de Steeg E; Wagenaar E; Vens C; Schinkel AH
Drug Metab Dispos; 2008 Apr; 36(4):631-40. PubMed ID: 18180270
[TBL] [Abstract][Full Text] [Related]
15. Modulation of human multidrug resistance protein (MRP) 1 (ABCC1) and MRP2 (ABCC2) transport activities by endogenous and exogenous glutathione-conjugated catechol metabolites.
Slot AJ; Wise DD; Deeley RG; Monks TJ; Cole SP
Drug Metab Dispos; 2008 Mar; 36(3):552-60. PubMed ID: 18079363
[TBL] [Abstract][Full Text] [Related]
16. A membrane vesicle-based assay to enable prediction of human biliary excretion.
Colombo F; Poirier H; Rioux N; Montecillo MA; Duan J; Ribadeneira MD
Xenobiotica; 2013 Oct; 43(10):915-9. PubMed ID: 23402371
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of transport-active multidrug resistance protein 2 (MRP2; ABCC2) in proteoliposomes.
Hagmann W; Schubert J; König J; Keppler D
Biol Chem; 2002 Jun; 383(6):1001-9. PubMed ID: 12222674
[TBL] [Abstract][Full Text] [Related]
18. Multidrug Resistance-Associated Protein 2 (MRP2) Mediated Transport of Oxaliplatin-Derived Platinum in Membrane Vesicles.
Myint K; Li Y; Paxton J; McKeage M
PLoS One; 2015; 10(7):e0130727. PubMed ID: 26131551
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of mouse and monkey multidrug resistance-associated protein 2 (Mrp2).
Ninomiya M; Ito K; Hiramatsu R; Horie T
Drug Metab Dispos; 2006 Dec; 34(12):2056-63. PubMed ID: 16936067
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships for interaction with multidrug resistance protein 2 (ABCC2/MRP2): the role of torsion angle for a series of biphenyl-substituted heterocycles.
Lai Y; Xing L; Poda GI; Hu Y
Drug Metab Dispos; 2007 Jun; 35(6):937-45. PubMed ID: 17371800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
